Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD

The most promising approaches are JAK inhibition and fecal microbiota transplantation. In this pilot study we evaluate this combination treatment in the first line.

acute graft-versus-host disease
ruxolitinib
graft versus host disease
  • 0 views
  • 16 Feb, 2024
  • 1 location
Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology

This research consists of two parts: part 1: development of microbiome biomarkers for immuno-oncology part 2: proof-of-concept trial on the fecal microbiota transplantation in patients who are being treated with immunotherapy for advanced solid tumor

diarrhea
tuberculosis
prednisone
international travel
vitiligo
  • 0 views
  • 16 Feb, 2024
  • 1 location
Gut Microbiome in Biliary Atresia

The establishment of gut-liver axis, featured by cholangitis and gut-microbiome will open new pathway to treat the BA using fecal microbiota transplantation. Analysis of gut-microbiome: The investigator will investigate the alteration of gut-microbiome by restoration of bile flow at diagnosis, before and after Kasai procedure.

neonatal hepatitis
biliary atresia
cholestasis
portoenterostomy
vaccination
  • 0 views
  • 16 Feb, 2024
  • 1 location
Innovative Approach to Fecal Microbiota Transplantation (FMT) Applied for Chronic Kidney Disease (CKD)

In a variety of chronic-degenerative and infectious diseases, the "fecal microbiota transplantation" (FMT) is being tested in recent years in addition with the application of both probiotics and prebiotics. FMT is indeed currently successfully used in the eradication of recurrent Clostridium difficile infections, with success rates of 90%, thus recent …

nephropathy
chronic disease
microbiota
  • 0 views
  • 16 Feb, 2024
  • 1 location